$225 Million

Establishment Labs

Sole Placement Agent & Exclusive Financial Advisor, April 2022

Senior Secured Term Loan

Establishment Labs Holdings Inc. is a global medical device company that designs, develops, manufactures, and markets innovative breast augmentation and reconstruction products, tools, and techniques. The Company primarily provides clinically and commercially differentiated Motiva breast implants, which demonstrate improved biocompatibility from nanosurface technology and offer enhanced ergonomic design with proprietary silicone formulations. The Company recently launched Flora, a novel tissue expander that includes a magnet-free RFID port, which provides top-line breast reconstruction outcomes to women following breast cancer. The Company is also in the process of launching Motiva Mia, a minimally-invasive breast augmentation procedure that significantly reduces operation and recovery times and has the potential to expand the total addressable market. The Company currently sells its products in Europe, Latin America, and the Asia-Pacific via exclusive distributors and direct sales, and it plans to expand into the United States and China in the near term.

More Like This

Apr 2022
$73.1 Million

Registered Direct Offering

Bookrunner

View Details
Apr 2022
Proven Behavior Solutions Logo

Strategic Investment From Health Enterprise Partners

Exclusive Financial Advisor

View Details
Apr 2022

Majority Stake in FotoFinder Systems GmbH

M&A and Debt Advisor

View Details